Loading…
Loading…
This exchange-traded fund endeavors to replicate the financial outcomes of a designated benchmark index, which assesses the investment appreciation of equities within the healthcare sector. It operates under a passive management style, generally utilizing a full replication strategy; however, a sampling approach may be adopted when necessitated by regulatory requirements. The fund's portfolio is comprised of shares from enterprises engaged in providing medical or health-related goods, services, technological innovations, or equipment.
Is VHT's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
Vanguard Health Care ETF offers a significantly lower expense ratio of 0.09% compared to 0.38% for iShares U.S. Pharmaceuticals ETF iShares U.S. Pharmaceuticals ETF has delivered higher total returns over the last five years but carries higher concentration risk with only 56 holdings Vanguard Health Care ETF provides broader sector diversification by covering the entire medical ecosystem while the iShares fund focuses strictly on drug manufacturers
Vanguard Health Care ETF offers a lower expense ratio and higher dividend yield than Invesco Pharmaceuticals ETF Invesco Pharmaceuticals ETF has concentrated its portfolio in 29 pharmaceutical stocks whereas Vanguard Health Care ETF holds 411 healthcare companies Invesco Pharmaceuticals ETF significantly outperformed on a 1-year total return basis
JNJ's 25% year-to-date surge and recent FDA approval fuel interest in healthcare ETFs with diversified sector exposure.
Market jitters return on fresh U.S.-Iran tensions. Energy, dividend, low-volatility and defensive ETFs could help investors navigate renewed uncertainty.
VHT offers broad diversification across 429 healthcare holdings, while PPH concentrates on 26 drugmakers for higher growth potential.